Project Description: Advance the development of oral delivery in humans of the designer NP CD-NP and the development of a novel GC-A/-B acfivator tailored for cardiorenal disease.
|Effective start/end date||8/18/11 → 5/31/16|
- National Heart, Lung, and Blood Institute: $320,543.00
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.